Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses - PubMed (original) (raw)
Review
Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses
Sara E Mole et al. Neurogenetics. 2005 Sep.
Abstract
The neuronal ceroid lipofuscinoses (NCLs) are a group of severe neurodegenerative diseases with onset usually in childhood and characterised by the intracellular accumulation of autofluorescent storage material. Within the last decade, mutations that cause NCL have been found in six human genes (CLN1, CLN2, CLN3, CLN5, CLN6 and CLN8). Mutations in two additional genes cause disease in animal models that share features with NCL-CTSD in sheep and mice and PPT2 in mice. Approximately 160 NCL disease-causing mutations have now been described (listed and fully cited in the NCL Mutation Database, http://www.ucl.ac.uk/ncl/ ). Most mutations result in a classic morphology and disease phenotype, but some mutations are associated with disease that is of later onset, less severe or protracted in its course, or with atypical morphology. Seven common mutations exist, some having a worldwide distribution and others associated with families originating from specific geographical regions. This review attempts to correlate the gene, disease-causing mutation, morphology and clinical phenotype for each type of NCL.
Similar articles
- The genetic spectrum of human neuronal ceroid-lipofuscinoses.
Mole SE. Mole SE. Brain Pathol. 2004 Jan;14(1):70-6. doi: 10.1111/j.1750-3639.2004.tb00500.x. Brain Pathol. 2004. PMID: 14997939 Free PMC article. Review. - Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
Mole SE, Mitchison HM, Munroe PB. Mole SE, et al. Hum Mutat. 1999;14(3):199-215. doi: 10.1002/(SICI)1098-1004(1999)14:3<199::AID-HUMU3>3.0.CO;2-A. Hum Mutat. 1999. PMID: 10477428 Review. - [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis].
Taschner PE, Losekoot M, Breuning MH, Hofman I, van Diggelen OP. Taschner PE, et al. Ned Tijdschr Geneeskd. 2005 Feb 5;149(6):300-3. Ned Tijdschr Geneeskd. 2005. PMID: 15730038 Review. Dutch. - Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins.
Kyttälä A, Lahtinen U, Braulke T, Hofmann SL. Kyttälä A, et al. Biochim Biophys Acta. 2006 Oct;1762(10):920-33. doi: 10.1016/j.bbadis.2006.05.007. Epub 2006 Jun 3. Biochim Biophys Acta. 2006. PMID: 16839750 Review. - The molecular genetic basis of the neuronal ceroid lipofuscinoses.
Gardiner RM. Gardiner RM. Neurol Sci. 2000;21(3 Suppl):S15-9. doi: 10.1007/s100720070035. Neurol Sci. 2000. PMID: 11073223 Review.
Cited by
- Vacuolar hydrolysis and efflux: current knowledge and unanswered questions.
Parzych KR, Klionsky DJ. Parzych KR, et al. Autophagy. 2019 Feb;15(2):212-227. doi: 10.1080/15548627.2018.1545821. Epub 2018 Nov 22. Autophagy. 2019. PMID: 30422029 Free PMC article. Review. - Pathophysiology of neuropathic lysosomal storage disorders.
Bellettato CM, Scarpa M. Bellettato CM, et al. J Inherit Metab Dis. 2010 Aug;33(4):347-62. doi: 10.1007/s10545-010-9075-9. Epub 2010 Apr 29. J Inherit Metab Dis. 2010. PMID: 20429032 Review. - Early recognition of CLN3 disease facilitated by visual electrophysiology and multimodal imaging.
Sakti DH, Cornish EE, Fraser CL, Nash BM, Sandercoe TM, Jones MM, Rowe NA, Jamieson RV, Johnson AM, Grigg JR. Sakti DH, et al. Doc Ophthalmol. 2023 Jun;146(3):241-256. doi: 10.1007/s10633-023-09930-1. Epub 2023 Mar 25. Doc Ophthalmol. 2023. PMID: 36964447 Free PMC article. - Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6.
Arsov T, Smith KR, Damiano J, Franceschetti S, Canafoglia L, Bromhead CJ, Andermann E, Vears DF, Cossette P, Rajagopalan S, McDougall A, Sofia V, Farrell M, Aguglia U, Zini A, Meletti S, Morbin M, Mullen S, Andermann F, Mole SE, Bahlo M, Berkovic SF. Arsov T, et al. Am J Hum Genet. 2011 May 13;88(5):566-73. doi: 10.1016/j.ajhg.2011.04.004. Epub 2011 May 5. Am J Hum Genet. 2011. PMID: 21549341 Free PMC article. - Analysis of potential biomarkers and modifier genes affecting the clinical course of CLN3 disease.
Lebrun AH, Moll-Khosrawi P, Pohl S, Makrypidi G, Storch S, Kilian D, Streichert T, Otto B, Mole SE, Ullrich K, Cotman S, Kohlschütter A, Braulke T, Schulz A. Lebrun AH, et al. Mol Med. 2011;17(11-12):1253-61. doi: 10.2119/molmed.2010.00241. Epub 2011 Aug 18. Mol Med. 2011. PMID: 21863212 Free PMC article.
References
- Brain Dev. 1988;10(2):80-3 - PubMed
- Lancet. 1996 Apr 13;347(9007):1014-5 - PubMed
- Nat Genet. 1999 May;22(1):55-8 - PubMed
- Prenat Diagn. 1993 Sep;13(9):833-41 - PubMed
- Hum Mol Genet. 2001 Jun 15;10(13):1431-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous